Perceptive Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Perceptive Advisors’s Portfolio SPRY Stock Details SPRY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Hold
2024 Q3	–	Sell
2024 Q2	$7.38M	Hold
2024 Q1	$8.86M	Buy